Добавил:
kiopkiopkiop18@yandex.ru t.me/Prokururor I Вовсе не секретарь, но почту проверяю Опубликованный материал нарушает ваши авторские права? Сообщите нам.
Вуз: Предмет: Файл:

Ординатура / Хирургия / Библиотека им академика М.И. Перельмана / Книга_936_Библиотеки_им_академика_М_И_Перельмана

.pdf
Скачиваний:
0
Добавлен:
31.08.2026
Размер:
31 Мб
Скачать
364
https://t.me/medicina_free
DYSPHAGIA ASSESSMENT AND TREATMENT PLANNING: A TEAM APPROACH
Vela, M. F., Richter, J. E., Wachsberger, D.,
Connor, J., & Rice, T. W. (2004). Com­plexities of managing achalasia at a ter­tiary referral center: Use of pneumatic dilatation, heller myotomy, and botuli­num toxin injection. American Journal of Gastroenterology, 99(6), 1029–1036. Sco­pus. https://doi.or g/10.1111/j.1572- 0241 .2004.30199.x
Wetscher, G. J., Glaser, K., Wieschemeyer,
T., Gadenstaetter, M., Prommegger, R., & Profanter, C. (1997). Tailored antireflux surgery for gastroesophageal reflux dis­ease: Effectiveness and risk of postopera­tive dysphagia. World Journal of Surgery, 21(6), 605–610. https://doi.org/10.1007/ s002689900280
Winter, H. S., Madara, J. L., Stafford, R. J.,
Grand, R. J., Quinlan, J. E., & Goldman,
H. (1982). Intraepithelial eosinophils: A new diagnostic criterion for reflux esophagitis. Gastroenterology, 83(4), 818–
823.
Xiao, Y., Kahrilas, P. J., Nicodème, F., Lin,
Z., Roman, S., & Pandolfino, J. E. (2014). Lack of correlation between HRM met­rics and symptoms during the manomet­ric protocol. American Journal of Gastro- enterology, 109(4), 521. https://doi.org/ .1038/ajg.2014.13
Yadlapati, R., Kahrilas, P. J., Fox, M. R.,
Bredenoord, A. J., Gyawali, C. P., Roman, S., . . . Pandolfino, J. E. (2021). Esopha­geal motility disorders on high resolu­tion manometry: Chicago Classification version 4.0. Neurogastroenterology and Motility, 33(1), e14058. https://doi.org/ 10 .1111/nmo.14058
10
Neurogenic Dysphagia
https://t.me/medicina_free
Jacqui E. Allen
Neurogenic disorders are among the most common etiologies responsible for swallowing dysfunction. A hetero­geneous group of pathologies must be considered that span acute-onset cen­tral disorders such as stroke; progres­sive, insidious disorders such as amy­otrophic lateral sclerosis (ALS); and peripheral neuromyogenic dysfunc­tion as seen in inflammatory myositis (Table 16–1). The effects of neuromus­cular dysfunction may also manifest in a variety of ways, including end-organ weakness or failure, incoordination of gestures, or total failure of central patterning. The underlying etiology determines which aspect of degluti­tion is most prominently affected and therefore which therapies may be effective in rehabilitating swallow or preventing complications of dyspha­gia. More than three quarters of cases of oropharyngeal dysphagia are due to neurological disorders (Diniz et al., 2009; White et al., 2008). Estimates of prevalence of swallow complaints are
65% in acute stroke, at least 50% in Parkinson’s disease (PD) and rises as duration of disease increases, around 30% in multiple sclerosis (MS), 30% to 100% in motor neuron disease (MND), and somewhere between 13% and 60% in dementia (Panebianco et al., 2020). Aspiration pneumonia, a consequence of swallow impairment, is a common cause of mortality in all neurogenic dis­eases. To offer the best diagnostic and treatment options to patients, we must understand basic pathophysiological mechanisms in these disorders and the most vulnerable portions of deglutition in each case.
This chapter will briefly present the most common neuromyogenic disor­ders related to dysphagia, characteris­tics of swallow impairments, and vid­eofluoroscopic findings specific to each. A brief discussion regarding optimum assessment of the patient (crucial in making the correct diagnosis and for­mulating a management strategy) is included (Miles & Allen, 2015).
365
366
https://t.me/medicina_free
DYSPHAGIA ASSESSMENT AND TREATMENT PLANNING: A TEAM APPROACH
Table 16 –1. Etiology of Neurogenic Dysphagia
CENTRAL PERIPHERAL
Nondegenerative Degenerative Neuromuscular Myopathy
Cerebrovascular Accident
Brain Injury
Medication
Neoplasm
Congenital cerebral palsy, syringobulbia, Arnold-Chiari malformation
Dementia Alzheimer’s disease, multi-infarct
Parkinson’s disease
Multiple sclerosis
Huntington’s disease
Supranuclear palsy
ASSESSMENT
The test battery approach in a multidis­ciplinary environment offers the best diagnostic accuracy and will provide the most useful information regarding diagnosis, prognosis, interventions, compensatory strategies, and dietary safety. Multiple methods are available to assess the dysphagic patient, and each provides complementary infor­mation that can be crucial to treatment planning in a team setting (Rugiu,
2007). Many of these strategies are dis­cussed in this book.
A thorough clinical evaluation by a trained swallowing professional such as a speech pathologist is the first step. While this is invaluable in identifying struggling patients and developing rapport, multiple studies have demonstrated that patients with
Myasthenia gravis
Polio, Post-polio syndrome
Amyotrophic lateral sclerosis
Neuropathy Iatrogenic
Guillain-Barré syndrome
Muscular dystrophies: Oculopharyngeal muscular dystrophy (OPMD), Myotonic (MD), Duchenne (DMD)
Polymyositis, Dermatomyositis, Inclusion body myositis
Post surgery or radiotherapy of the head and neck
neuromyogenic conditions frequently present with silent aspiration and can­not, by definition, be identified by bedside evaluation (Diniz et al., 2009; González-Fernández et al., 2008; Kang et al., 2011; Ramsey et al., 2003; Rugiu, 2007; Smithard, 2016; White et al., 2008). Sensitivity of the bedside examination ranges from 40% to 80% and specific­ity ranges from 59% to 91% (González­Fernández et al., 2008; Miles et al., 2013; Ramsey et al., 2003; Rugiu, 2007; Smithard, 2016). Cough reflex test­ing has been studied as an adjunct to bedside examinations, with the aim of improving detection of silent aspirators (Miles et al., 2013). It may assist in iden­tifying subjects requiring a comprehen­sive instrumental examination. Addi­tional adjunctive measures have been proposed such as measuring oxygen saturations or cervical auscultation, so
16. NEUROGENIC DYSPHAGIA
https://t.me/medicina_free
367
far without significant improvement in the rate of detection of silent aspirators (Marian et al., 2017; Smithard, 2016).
Instrumental examination is invalu­able for detecting silent aspiration and most commonly consists of a dynamic videofluoroscopic swallowing study (VFSS), also called a dynamic swallow study (DSS). The dynamic swallow study (Chapters 6–8) provides objective and quantitative data that can elaborate the nature and severity of a swallowing problem, provide insights into progno­sis in individual patients, and be used to develop remedial treatment pro­grams. It has been considered the “gold standard” in instrumental assessment (Carbo et al., 2021; González-Fernández et al., 2008; Kang et al., 2011; Ney et al., 2009; Rugiu, 2007). However, this radio­graphic study is two-dimensional and requires exposure to ionizing radiation (approximately that of two cervical spine x-rays), and specialized equip­ment and personnel are not always available to the assessing clinician. Consequently, the use and timing of the DSS must be considered with respect to minimizing both diagnostic costs and x-ray exposure, particularly in patient populations that experience frequent and significant change, sometimes rapid and for the better, sometimes pro­longed and for the worse.
An instrumental flexible endoscopic evaluation of swallowing (FEES; Chap­ter 4) may also identify aspiration, provide distinct laryngopharyngeal anatomical information that may com­plement the DSS, be performed at the bedside (useful in those patients unable to be transported to a radiology suite), and avoid the consequent risks of radia­tion exposure (most pertinent in young or multiply injured patients). Informa-
tion from FEES is complementary to videofluoroscopic study information, and both studies may be useful in any given patient (González-Fernández etal., 2008; Rugiu, 2007).
High-resolution pharyngoesopha­geal manometry is an expanding diag­nostic tool that may also be employed for biofeedback purposes. It measures the pressures along the aerodigestive tract, from velum to stomach and, if combined with impedence recording, can also demonstrate where the bolus is situated within the pharyngoesopha­geal lumen, through alterations in resis­tance (Panebianco, 2020).
Electromyography can be employed to delineate specific muscle activity from differing areas involved with swal­lowing, including masticatory muscles, tongue, floor of mouth, anterior cervi­cal area, and the upper esophageal sphincter (Panebianco, 2020). A battery of diagnostic strategies that permit the most efficacious collection of informa­tion in a practical and safe way should be the aim when assessing swallowing problems in neurogenic patients.
CENTRAL NERVOUS SYSTEM DISORDERS
A selection of common neuropathic conditions affecting deglutition will be discussed.
Cerebrovascular Accident (CVA)
Dysphagia is found in 29% to 80% of those presenting with an acute stroke (Diniz et al., 2009; Garon et al., 2009; González-Fernández et al., 2008; Kägi
368
https://t.me/medicina_free
DYSPHAGIA ASSESSMENT AND TREATMENT PLANNING: A TEAM APPROACH
et al., 2016; Kang et al., 2011; Kumar et al., 2010; Ney et al., 2009; Rugiu, 2007; Simons & Hamdy, 2017; Smithard,
2016). In many cases (50%–90%), rapid improvement may be expected over the short to medium term, but per­sistent dysphagia is seen in approxi­mately 20% to 50% of patients (Diniz etal., 2009; Garon et al., 2009; González­Fernández et al., 2008; Kägi et al., 2016; Rugiu, 2007; Smithard, 2016; White et al., 2008). More than half of those with acute stroke develop aspiration and 35% develop aspiration pneumo­nia (Ney et al., 2009; Panebiano et al.,
2020). Even a year later, 15% to 20% of post-CVA patients develop pneumonia and almost half of CVA patients are malnourished (Ney et al., 2009).
Swallowing function has bilateral cortical representation with intercon­necting crossed pathways at the level of the brainstem (González-Fernández et al., 2008; Panebianco et al., 2020; White et al., 2008). Medullary or pon­tine strokes result in severe dysphagia due to both sensory and motor disrup­tion (Flowers et al., 2017; Jones et al.,
2020). Injury involving the right pri­mary sensory cortex, right insula, left and right motor cortices, and midbrain structures including the internal cap­sule, thalamus, basal ganglia, and cere­bral peduncles may also affect degluti­tion and are increasingly delineated by a magnetic resonance imaging (MRI) scan (Dehaghani et al., 2016; Flowers et al., 2017). Dysphagia is therefore a prominent feature of brainstem and both right and left cortical insults (Jones et al., 2020; Kumar et al., 2010; Ney et al., 2009; Paliwal et al., 2009) and affects the oral and oropharyngeal phases of deglutition (Donner et al., 1985; Rugiu, 2007).
Sensory deficits (particularly if they affect the pharynx) also lead to signifi­cant dysfunction and may be a cause of silent aspiration. Therefore, injury at many sites can result in swallowing dif­ficulties. Furthermore, older adults who typically suffer from stroke may har­bor preexisting swallow impairments or physiological decline in swallow reserve (presbyphagia), which is then unmasked or exacerbated following another insult such as stroke (Smithard,
2016). As the picture changes over time, frequent reassessment is crucial (Kägi et al., 2016; Smithard, 2016).
Dysphagia after stroke is associ­ated with development of aspiration pneumonia (3- to 11-fold increased risk) (Altman et al., 2010; Feng et al., 2019; González-Fernández et al., 2008; Kumar et al., 2010; Ney et al., 2009; Rugiu, 2007; Smithard, 2016; White etal., 2008). Silent aspiration is com­mon after stroke (2%–66%) and may manifest only as recurrent pulmonary complications (González-Fernández et al., 2008; Ney et al., 2009; Ramsey et al., 2003, 2005; Rugiu, 2007). Aspiration pneumonia is the most common cause of rehospitalization in acute stroke patients and contributes to more than 50% of post-CVA deaths in the first 30days (Ney et al., 2009). In fact, aspira­tion pneumonia is the leading cause of death poststroke, and reduced oxygen­ation resulting from pneumonia may exacerbate neurological injury and slow recovery (Kang et al., 2011; Vilardell etal., 2017; White et al., 2008). In those with dysphagia following stroke, there is an adjusted hazard ratio of 1.84 for death within 5 years, compared to those without dysphagia (Feng et al., 2019). Because stroke also results in depres-
16. NEUROGENIC DYSPHAGIA
https://t.me/medicina_free
369
sion of the immune system, aspiration occurring post-CVA may be less well tolerated, increasing the rate of aspi­ration pneumonia. It is estimated that 5% to 15% of community-acquired pneumonia is caused by aspiration (White et al., 2008). Silent aspiration (by definition) is not detected by bedside evaluation and therefore a high index of suspicion is required to avoid miss­ing the diagnosis. Independent factors associated with greater risk of poor swallowing after stroke include older age, malnutrition at admission, larger lesion volume, brainstem involvement, corticobulbar involvement, white mat­ter involvement, presence of dysar­thria or dysphagia, cognitive impair­ment, and reduction in functional scale scores (e.g., Rankin Scale, Barthel index or National Institutes of Health Stroke Scale) (Jones et al., 2020).
Due to the high prevalence of dys­phagia in stroke patients, screening for swallowing problems should be under­taken in all patients, even those with no overt signs of dysphagia. Initially, a bedside assessment by a speech pathol­ogist or trained clinician should be per­formed. To improve sensitivity to swal­low impairment, addition of cervical auscultation, measures of oxygen satu­ration, or cough reflex testing has been proposed (Jones et al., 2020; Marian etal., 2017; Miles et al., 2013; Smithard, 2016; Vilardell et al., 2017). None of these methods is sensitive enough to reliably detect silent aspiration. In most cases involving hemispheric or brain­stem sites, an instrumental evaluation is indicated due to the high rate of silent aspiration (González-Fernández et al., 2008; Jones et al., 2020; Ney et al., 2009; Ramsey et al., 2003, 2005; Rugiu, 2007).
Patients presenting with additional risk factors for aspiration (based on site of lesion, comorbidities, age, pul­monary health, head and neck cancer, dementia, cervical spine abnormali­ties) should be identified and should also undergo instrumental evaluation regardless of findings of bedside or clinical evaluations.
Instrumental examination may con­sist of videofluoroscopy (DSS), endos­copy (FEES), or both. DSS and FEES both demonstrate high sensitivity and specificity in identifying aspiration (>85%) (Ramsey et al., 2005; Rugiu,
2007). The DSS will also demonstrate pharyngoesophageal and esophageal phase abnormalities. Fluoroscopic stud­ies help delineate the mechanism of dysphagia, allow assessment of com­pensatory maneuvers, and contribute to planning of safe swallow strategies. Visualization of the vocal folds is not possible with DSS, though mobility may be appreciated with a voicing task performed in the anterior-posterior view. FEES permits ready examina­tion of the vocal folds and may allow assessment of asymmetry (e.g., uni­lateral weakness, sensory change, or obstruction) and will assist in tailoring compensatory strategies.
High-resolution pharyngeal manom­etry (HRPM) provides information regarding pharyngeal pressure genera­tion, and those with poststroke dyspha­gia demonstrate decreased pharyngeal propulsive pressures and abnormal upper esophageal sphincter nadir pres­sures. In addition, HRPM has identified pharyngeal missequencing (simultane­ous pharyngeal pressure generation) as characteristic of poststroke swallow behavior (Jones et al., 2020). Therefore,
370
https://t.me/medicina_free
DYSPHAGIA ASSESSMENT AND TREATMENT PLANNING: A TEAM APPROACH
information obtained from these stud­ies is complementary, and often one or more are required to devise the best treatment strategy.
Clinical factors that suggest the need for evaluation with a DSS include (a) aspiration pneumonia; (b) cough, “wet voice,” and “wet lung” follow­ing swallowing; and (c) inability to maintain oral hydration and nutrition. The DSS is of value in identifying the presence of aspiration, and the effects of various remedial strategies, even with no quantitative assessment. Our experience, however, suggests that the extra time and expense associated with obtaining objective displacement and timing measures can contribute signifi­cantly to patient care. Our research has demonstrated that a pharyngeal transit time of greater than 5 seconds (normal
1.00 ± 0.15 seconds) is significantly associated with aspiration pneumonia risk in stroke patients, while a time of less than 2 seconds has a low associa­tion (Johnson & McKenzie, 1993; John­son et al., 1992).
Timing of Evaluations
Following a CVA, a patient’s symptoms may undergo rapid change. Timing of evaluations and frequent reassessment are therefore critical. Early speech pa­thology (SP) assessment should follow initial screening tests (usually within 3 days of admission), to evaluate the patient’s ability to handle oral intake and to provide a baseline for consis­tent follow-up assessment. Thereafter, additional SP input may vary — how­ever, repeated evaluations improve patient outcomes. Reassessment and education around rehabilitative strate­gies reduce the number of days with-
out oral intake (Nakazora et al., 2017). In many cases of acute stroke, dyspha­gia improves rapidly. Factors that sug­gest a prolonged period of dysphagia (>2 weeks) include failure to cleanly swallow 50mL of water, modified Bar­thel Index <20, dysphasia, insular or frontal cortex involvement, and Par­ramatta Hospitals’ Dysphagia Index Score <70 (Vilardell et al., 2017; White et al., 2008).
As the DSS exposes the patient to radiation, one must be careful to utilize the study at the appropriate time and maximize the amount of information obtained from each study (Chau et al.,
2009). Early fluoroscopic examination may be necessary for identification of silent aspiration and pharyngeal residue or suspected cricopharyngeal or esophageal problems. Subsequent examinations may be scheduled after a therapeutic trial, when significant motor improvements have been noted (or deterioration seen) or when sen­sory changes have occurred. FEES examinations may be performed more frequently if trained staff are available, as this does not expose the patient to radiation. FEES also offers the possi­bility of visual feedback to the patient, which can be of great value in teaching compensatory strategies, if a viewing screen is utilized. Furthermore, bio­feedback techniques utilizing manom­etry can be selected to “train” an indi­vidual to reach a target or implement an action and focus on skill training as opposed to simply increasing strength (Jones etal., 2020).
DSS Findings
Stroke often affects the nucleus ambig­uus in the brainstem, which provides
16. NEUROGENIC DYSPHAGIA
https://t.me/medicina_free
371
motor output to the pharynx and esophagus, resulting in pharyngo­esophageal abnormalities. Pharyngeal weakness, prolonged pharyngeal tran­sit time, aspiration, cricopharyngeal dysfunction, and esophageal dysmotil­ity are common findings (Jones et al., 2020; Rugiu, 2007). Tongue dysfunc­tion may be noted if the hypoglossal nucleus, situated more caudally in the brainstem, has been involved. Corti­cal strokes may produce facial asym­metry and weakness that can result in oral incompetence and poor oral bolus control. This may manifest with signif­icant oral and pharyngeal residue on DSS, which increases the risk of aspira­tion (Johnson et al., 1992; Rugiu, 2007; Schimmel et al., 2017). Johnson et al. (1992) demonstrated that prolongation of pharyngeal transit times over 1 sec­ond was associated with a significant increase in airway penetration and aspiration and with occurrence of aspi­ration pneumonia. This was also the finding in Kang et al.’s (2011) study of 39 post-CVA patients. Loss of sensory function within the oropharynx and airway will also impair swallow by reducing bolus awareness and airway protection. Penetration and aspiration may occur without a response (e.g., silent aspiration), or the cough response may only occur once material reaches the carina.
Summary
CVA is a leading cause of oropha­ryngeal and esophageal dysphagia. Dysphagia may be short-lived, but in approximately 50% of patients, it will be prolonged >2 weeks. Dysphagia is the primary risk factor for aspiration pneumonia, which is the leading cause
of death after stroke. Aspiration may be silent in up to two thirds of patients after stroke. Instrumental evaluation is therefore critical in assessing these patients. DSS provides reliable informa­tion about the swallow from oral cavity to stomach. It may be complemented by information from other instrumental evaluations. The DSS provides accu­rate quantitative data that can be used to formulate treatment and rehabilita­tive strategies and demonstrate change over time. Thoughtful performance of DSS and careful poststudy analysis will maximize the benefit obtained from flu­oroscopic evaluation.
Parkinson’s Disease
Dysphagia is common in patients suf­fering from Parkinson’s disease (PD), a progressive motor system disease caused by failed central dopamine pro­duction (Merola et al., 2011). Histopath­ological studies demonstrate degen­eration of pharyngeal motor nerves, indicating that oropharyngeal dyspha­gia in PD occurs from direct involve­ment of motor supply to pharyngeal musculature as well as lack of central dopamine (Mu et al., 2013). Braak and Del Tredici (2003) proposed that PD develops from peripheral insults that propagate centrally, and studies of axo­nal movement of α-synuclein support this proposition. Other theories include mitochondrial dysfunction resulting in generation of damaging reactive oxy­gen species and inflammation in the brain that is driven by cytotoxic T cells and microglia (Moradi Vastegani et al., 2023; Sohrabi et al., 2023).
Along with voice deterioration, dys­phagia is often one of the presenting
372
https://t.me/medicina_free
DYSPHAGIA ASSESSMENT AND TREATMENT PLANNING: A TEAM APPROACH
symptoms of PD. Altman et al. (2010) demonstrated that admission to hos­pital with a symptom of dysphagia was significantly associated with Par­kinson’s disease (relative risk = 4.5) compared with age- and sex-matched patients admitted without dyspha­gia. Prevalence of dysphagia in PD is estimated to be between 32% and 70% but increases with disease severity and duration, and it remains underreported when compared with the objective prevalence rate (80%) (Kalf et al., 2012; Luchesi et al., 2015; Merola et al., 2011).
Despite a high incidence of dyspha­gia, PD sufferers may not complain of swallow problems even with demon­strable objective evidence of dysfunc­tion (Cosentino et al., 2022; Kalf et al., 2012; Luchesi et al., 2015). Swallow dys­function remains the leading cause of mortality in PD patients secondary to aspiration pneumonia (Cosentino et al., 2022; Hobson & Meara, 2018; Kalf et al., 2012; Kulisevsky et al., 2018; Nicaretta et al., 2013; Videira & Castro-Caldas,
2018). Rodrigues et al. (2011) identi­fied silent aspiration of saliva on FEES exam in 10% (penetration in 29%) of PD patients, with a reduction in laryngeal sensitivity in 90% of tested individuals. The rate may be greater during meals. Aspiration pneumonia rates are three­fold higher in PD subjects compared to age-matched controls (Cosentino etal.,
2022).
In patients with PD, solid foods are often more difficult to swallow than liquids as the suprahyoid musculature may be significantly affected (González­Fernández et al., 2008; Luchesi et al.,
2015). Difficulty swallowing pills, glo­bus sensation, coughing during meals, postswallow voice changes, and chest infections may be early signs of swallow
impairment in the PD patient (Cosen­tino et al., 2022). PD patients aged over 63, with high levodopa doses and gait difficulty or postural instability, dem­onstrate increased risk of developing dysphagia (Cosentino et al., 2022).
The hypokinesia that characterizes limb and truncal movements in PD appears to slow initiation of the swal­low sequence at the oral cavity and then prolong laryngeal and esophageal movements (González-Fernández et al., 2008; Rugiu, 2007). A high prevalence of esophageal dysfunction is seen in PD patients as diagnosed by high-resolu­tion manometry (Cosentino et al., 2022). Sialorrhea may result and stasis and residue may be seen on contrast studies (Nicaretta et al., 2013). Electrophysio­logical studies of patients with PD have demonstrated marked delay in trigger­ing swallow, extremely prolonged pha­ryngeal swallow durations, and normal cricopharyngeal muscle contractions (Ertekin et al., 2002). Oropharyngeal coordination may be impaired and muscle rigidity may affect bolus transit through the pharynx and into the pha­ryngoesophageal segment (PES), even with a compliant sphincter (Nicaretta et al., 2013).
A videofluoroscopic study of 34 pa­tients with swallowing complaints and Parkinson’s disease was conducted using the objective measures of event timing and structural displacement described in Chapter 8 of this book. That study identified a delay in airway closure to be present in 62% of patients and poor pharyngeal constriction to be present in 30.4%. No evidence of pro­longed pharyngeal transit times, poor hyoid elevation, or cricopharyngeal achalasia were identified (Ellerston etal., 2016).
16. NEUROGENIC DYSPHAGIA
https://t.me/medicina_free
373
Early screening or assessment of swallow, particularly with instrumen­tal tools, in those with PD is recom­mended, particularly as voice and swallow symptoms respond poorly to pharmacotherapies given for PD or to deep brain stimulation.
Motor Neuron Diseases: Amyotrophic Lateral Sclerosis (ALS)
Motor neuron diseases (MNDs) encom­pass a range of disorders that are clas­sified depending on the type of motor neuron subset that is affected. ALS involves both upper and lower motor neurons and causes dysfunction at both bulbar and spinal levels, and dyspha­gia is a common manifestation (Ertekin et al., 2000; González-Fernández et al., 2008; Ramroop & Cruz, 2022; Rugiu,
2007).
ALS is a progressive, neurodegen­erative disease that destroys nerve cells in the brain and spinal cord. Bulbar dysfunction at presentation is apparent in 20% of patients (Ramroop & Cruz, 2022). Over time, dysphagia becomes almost ubiquitous, leading to aspiration pneumonia in approxi­mately 15% of patients (Ertekin et al., 2000; González-Fernández et al., 2008). Solid food dysphagia is usually the first manifestation of swallowing dif­ficulty, but symptoms may eventually be more global, with abnormal swal­low patterning and rhythmicity, fre­quent pharyngeal residue, penetration, and aspiration (Aydogdu et al., 2011). Dysphagia affects quality of life in ALS patients and is a significant source of morbidity (Ertekin et al., 2000). Patients may describe a globus sensation due
to poor pharyngeal transit and poor trans-sphincteric flow due to upper esophageal sphincter (UES) dysfunc­tion (Ertekin et al., 2000; Rugiu, 2007). Poor oral and tongue control (muscle may fasciculate or atrophy), delayed pharyngeal transit, and UES dysfunc­tion are often present and well delin­eated by DSS (Aydogdu et al., 2011; Ertekin et al., 2000). These investiga­tors performed EMG studies in 43 ALS patients and demonstrated prolonged hyolaryngeal elevation, reduced and uncoordinated UES opening, and loss of voluntarily initiated swal­low sequence (Aydogdu et al., 2011; Ertekin et al., 2000). Electrodiagnostic testing is key to confirming diagnosis, and identifying motor neuron diseases and subtypes (nerve conduction stud­ies and EMG; Ramroop & Cruz, 2022) (Table 16–2). To quantify impairment, a recently developed questionnaire, the DYALS (dysphagia in amyotrophic lateral sclerosis), has been adapted from the DYMUS questionnaire used in multiple sclerosis (see below under Multiple Sclerosis heading). This ques­tionnaire correlates with EAT-10 scores and indicates worse swallowing in bul­bar ALS patients compared to spinal ALS patients, as expected (Diamanti etal., 2022).
In MND/ALS disorders, both struc­tural and functional swallow abnor­malities are present and contribute to airway violation prior to, during, and after swallow. Aspiration is often silent and may be accompanied by cogni­tive dysfunction (Printza et al., 2021). Tongue weakness is also a feature and correlates with higher EAT-10 scores, increased aspiration, more pharyngeal secretions and decreased pharyngeal efficiency (Printza et al., 2021). Because